SynopsisImmunochemistry diagnostic devices and equipment are designed to diagnose diseases or conditions by studying the functions of the immune system through analyzing the nature of specific proteins, antigens, antibodies, and their interaction. The global Imm.....
SynopsisBrain tumor drugs are used to treat brain tumors to prevent, inhibit, and eliminate brain cancer cells from various aspects, so that the patient's symptoms can be controlled, alleviated or eliminated. The global Brain Tumor Drugs market was valued at US$.....
SynopsisBladder cancer drugs are used to treat bladder cancer, prevent, inhibit, and eliminate bladder cancer cells from various aspects, so that the patient's symptoms can be controlled, alleviated or eliminated. The global Bladder Cancer Drugs market was value.....
SynopsisAntiglaucoma drugs are drugs used to diagnose, cure, treat or prevent glaucoma diseases. The global Antiglaucoma Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast pe.....
SynopsisConjugated Monoclonal Antibodies are used to treat cancer because they deliver toxic substances directly to tumor cells by reducing damage to normal cells in other parts of the body. The global Conjugated Monoclonal Antibodies market was valued at US$ mi.....
SynopsisBiosimilar therapeutic peptides are used as replacement therapies which supplements peptide hormones when the endogenous levels tend to decrease. The global Biosimilar Therapeutic Peptides market was valued at US$ million in 2023 and is anticipated to re.....
SynopsisLymphocyte modulators are intended as an aid in the treatment for cancer and autoimmune diseases, and for regulating carotene intake in humans with a weak immune system. The global Biosimilar Lymphocyte Modulator market was valued at US$ million in 2023 .....
SynopsisHypolipidemic drugs can be used to prevent cardiovascular diseases and atherosclerosis in Hyperlipidemia patients. The global Hypolipidemic Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR .....
SynopsisTNF Alpha Inhibitor are a group of medicines that suppress the body's natural response to tumor necrosis factor (TNF), a protein produced by white blood cells that is involved in early inflammatory events. The global TNF Alpha Inhibitor market was valued.....
SynopsisAnti-thyroid class of drugs are also called thionamides which block the formation of thyroid hormone from over active thyroid gland. The global Anti-Thyroid Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, w.....
